Rhaeos

Open enrollment across a mixed-phase pipeline

According to ClinicalTrials.gov-derived indexes, Rhaeos sits in the top decile of US sponsors by registered trial count (#934 of 15,742 sponsors by registered trial count).

15 total trials 5 currently recruiting 4 completed top decile by trial count

Rhaeos: 15 sponsored US clinical trials, 5 recruiting.

Rhaeos sponsors 15 registered US clinical trials on ClinicalTrials.gov, 5 of them currently recruiting, and 4 completed. The most-studied condition in this pipeline is Hydrocephalus, with 6 trials.

Top-decile sponsor footprint

Rhaeos ranks in the top decile of sponsors by registered trial count (#934 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Open and recent trials

15 total, page 1 of 1

RECRUITING NA

Flow Detection in Open and Closed Shunt Valve Periods

NCT07478926

RECRUITING NA

Assessment Intravenous Site Events During Outpatient Infusion Procedures With a Wireless Thermal Measurement Device During

NCT07009405

RECRUITING NA

Assessment of CSF Shunt Flow and Headaches With a Thermal Measurement Device

NCT06996600

RECRUITING NA

Longitudinal Measurements of Flow in Cerebrospinal Fluid Shunts With a Wireless Thermal Anisotropy Measurement Device

NCT06086561

RECRUITING

Formative Usability Assessment of Wireless Thermal Anisotropy Devices

NCT06040697

NOT YET RECRUITING NA

Study of Shunt Flow Under Different Valve Settings Using a Wireless Sensor

NCT07679035

NOT YET RECRUITING NA

Assessment of CSF Shunt Flow During Activities of Daily Living and Sleep With a Thermal Measurement Device

NCT07050628

NOT YET RECRUITING

Assessment of Flow in Cerebrospinal Fluid Shunts With a Second Generation Wireless Thermal Anisotropy Measurement Device

NCT06409286

NOT YET RECRUITING NA

Assessment of Flow in Cerebrospinal Fluid Shunts With a Wireless Thermal Anisotropy Measurement Device in Asymptomatic Patients

NCT06410885

COMPLETED NA

Assessment of CSF Shunt Flow in an Outpatient Setting with a Thermal Measurement Device

NCT06753929

TERMINATED

Functional and Non-Functional CSF Shunt Flow Measured With a Second-Generation Wireless Thermal Device

NCT06506045

COMPLETED

Flow Measurements in Functional CSF Shunts and Off-Shunt Locations with a Second-Generation Thermal Device

NCT06524492

TERMINATED

Measurements of CSF Shunts and Off-Shunt Locations With Wireless Thermal Anisotropy Measurement Devices

NCT06513572

COMPLETED

Assessment of CSF Shunt Flow With Thermal Measurements B

NCT05432986

COMPLETED

Assessment of CSF Shunt Flow With Thermal Measurements A

NCT05015751

What is open in the Rhaeos pipeline

5 recruiting of 15 indexed (33% open); 4 completed (27%).

Phase labels are sparse on this sponsor index, so phase mix is not charted here.

Top condition: Hydrocephalus (6 trials), 2 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Rhaeos: open-pipeline peers nationwide

Peers matched on 15 registered trials and 33% open enrollment, not the therapeutic-area sidebar.

Rhaeos sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 05101520 0%10%20%30%40% Total trials Recruiting share RhaeosAllakosArbor Research Collaborative for HealthArena PharmaceuticalsArrowhead PharmaceuticalsAadi BioscienceAaron CookAbivax S.A.Actuated Medical
Rhaeos sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Rhaeos sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 15 trials (± recruiting share)

Sponsors near 33% open enrollment (± trial volume)

What to do with this Rhaeos page

15 registered trials is a research-attention snapshot, not an endorsement of Rhaeos or any single study.

  • 5 of Rhaeos's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Hydrocephalus is the condition Rhaeos studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Hydrocephalus trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Rhaeos pipeline card: 15 registered trials from official public datasets.Report a data error.